Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Telbivudine on Renal Function in Chronic Hepatitis B Patients With Mild to Moderate Renal Impairment

NCT03778567 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT03778567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03778567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Telbivudine on Renal Function in Chronic Hepatitis B Patients With Mild to Moderate Renal Impairment
Lead sponsor
The University of Hong Kong
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2013
Completion date
May 31, 2018
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, hepatitis b, chronic